Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11,236 GBX | -0.12% | +3.57% | +6.28% |
03:38pm | AstraZeneca's Voydeya Approved as Add-on Therapy in Europe for Blood Disorder | MT |
10:50am | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC